STOCK BASED COMPENSATION | 8. STOCK-BASED COMPENSATION Stock-based compensation awards consist of stock options, restricted stock units and bonus shares issued under the Company’s equity incentive plans which include the 2013 Omnibus Incentive Plan (the “2013 Plan”) and the Amended and Restated 2004 Directors’ Stock Option and Restricted Stock Plan (the “2004 Directors’ Plan”). Upon approval of the 2013 Plan by the Company’s stockholders on June 4, 2013, the Company’s authority to grant new awards under all plans other than the 2013 Plan was terminated. On July 18, 2017, April 18, 2019, April 28, 2020, and May 21, 2021, the Company’s stockholders approved amendments to the 2013 Plan to increase the authorized number of shares of common stock available and reserved for issuance under the 2013 Plan by 20,000, 66,000, 350,000, and 1,500,000 shares, respectively, and in 2017 re-approved the material terms of the performance goals under the plan. Under the 2013 Plan, the Company may grant awards of stock options, stock appreciation rights, restricted stock awards, restricted stock units (“RSUs”), unrestricted stock, dividend equivalent rights, performance shares and other performance-based awards, other equity-based awards and cash bonus awards to eligible persons. Equity awards under the 2013 Plan are granted from time to time at the discretion of the Compensation Committee of the Board (the “Committee”), with vesting periods and other terms as determined by the Committee with a maximum term of 10 years. The 2013 Plan is administered by the Committee, which can delegate the administration to the Board, other Committees or to such other officers and employees of the Company as designated by the Committee and permitted by the 2013 Plan. As of September 30, 2021, 1,223,939 shares were available for future issuances under the 2013 Plan. For the three and nine months ended September 30, 2021, the Company recorded stock-based compensation expense of $0.3 million and $0.6 million, respectively. Stock compensation expense is recorded in general and administrative expenses. Stock Options The following tables summarize stock options outstanding and changes for the nine months ended September 30, 2021 and 2020: September 30, 2021 September 30, 2020 Weighted Weighted Number of Average Number of Average Stock Exercise Stock Exercise Options Price Options Price Stock options outstanding at beginning of period 185,054 $ 7.99 37,786 $ 37.42 Granted 94,522 3.91 125,804 1.59 Expired (2,000) 73.54 (1,693) 101.64 Stock options outstanding at end of period 277,576 6.18 161,897 9.25 Stock options exercisable at end of period 183,054 $ 7.35 36,093 $ 34.41 The following table summarizes stock options outstanding and exercisable by stock option plan at September 30, 2021: Outstanding Stock Options Exercisable Stock Options Number of Weighted Number of Weighted Outstanding Average Stock Options Average Stock Option Plan Stock Options Exercise Price Exercisable Exercise Price 2004 Plan 92 $ 1,638.00 92 $ 1,638.00 2004 Directors’ Plan 3 10,380.00 3 10,380.00 2013 Plan 277,481 5.53 182,959 6.36 277,576 $ 6.18 183,054 $ 7.35 Restricted Stock Units Time-based and performance-based RSUs are valued using the closing share price of the Company’s common stock on the date of grant. The final number of shares issued under performance-based RSUs is generally based on the Company’s prior year performance as determined by the Committee at each vesting date, and the valuation of such awards assumes full satisfaction of all performance criteria. The following table summarizes RSU activity for the nine months ended September 30, 2021 and 2020: September 30, September 30, 2021 2020 Weighted- Weighted- Average Average Number of Grant Date Number of Grant Date RSUs Fair Value RSUs Fair Value Unvested RSUs at beginning of period 236,403 $ 2.10 — $ — Granted 240,125 3.93 211,497 2.03 Forfeited — — — — Vested (78,801) 2.10 — — Unvested RSUs at end of period 397,727 $ 3.20 211,497 $ 2.03 |